Vermillion, Inc., a bio-analytical solutions company with a specialization in gynecologic diseases, recently appointed a new General Manager of their CLIA-certified national clinical laboratory, ASPiRA LABS. Patrick Carpenter will be bringing more than three decades of clinical expertise in laboratory operations and management to Vermillion, and will be reporting directly to the Company’s President and Chief Executive Officer, Valerie Palmieri.
Before receiving his new appointment, Carpenter held the position of Vice President of Operations/General Manager at Miraca Life Sciences, where he oversaw an anatomy and pathology laboratory that turns over about $60 million in yearly revenue. Before his time at Miraca, he worked under several prominent clinical laboratories, such as DIANON Systems, VCA/Antech Diagnostics, and Quest Diagnostics, as a senior operations consultant and other operations and management positions.
“Pat has reported to me in previous positions and will be a major asset to our management team,” said Palmieri. “Pat has significant industry experience and an intimate understanding of how to run a very profitable and efficient laboratory. We look forward to his contributions in leading our recently established ASPiRA LABS, which we view as a critical component of our evolution from a diagnostic company to a bio-analytic solutions provider.”
Aside from his credentials and experience in the field of laboratory operations and management, Carpenter is also a US Air Force Reserve Colonel. He completed an M.S. in Biomedical Chemistry at Thomas Jefferson University, and his M.A. in Health Services Management at Webster University, and graduated with a degree in Business and Management from the University of Maryland.
Vermillion is known for its flagship diagnostic product, OVA1® — a blood test capable of detecting malignancy in ovarian tumors through a novel algorithmic method. It is the first protein-based, in vivo Diagnostic Multivariate Index Assay to be approved by the US Food and Drug Administration, and represents a great leap forward in the field of software-based diagnostics.
In other news on diagnostic and screening tools, the National Institute of Justice recently commissioned Brad Cannell, Ph.D. to develop DETECT — a tool medical professionals can use to assess and identify potentially abused elderly. Cannell will be operating on a $370,000 grant to devise an easy yet thorough assessment method that can help facilitate clearer case reports to Adult Protective Services.